Effects of corticosteroids on adults with tuberculous meningitis admitted to intensive care unit: a propensity score analysis

The beneficial effect of corticosteroids has been well established, particularly in patients free of infection with the human immunodeficiency virus. In intensive care units, the high risks of infection to which patients are exposed specifically could offset the neurological benefit of corticosteroi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:La revue de medecine interne 2009-01, Vol.30 (1), p.12-19
Hauptverfasser: Madani, N, Dendane, T, Zekraoui, A, Abidi, K, Zeggwagh, A A, Abouqal, R
Format: Artikel
Sprache:fre
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 19
container_issue 1
container_start_page 12
container_title La revue de medecine interne
container_volume 30
creator Madani, N
Dendane, T
Zekraoui, A
Abidi, K
Zeggwagh, A A
Abouqal, R
description The beneficial effect of corticosteroids has been well established, particularly in patients free of infection with the human immunodeficiency virus. In intensive care units, the high risks of infection to which patients are exposed specifically could offset the neurological benefit of corticosteroids. The purpose of the study was to assess the effects of corticosteroids in adult patients with tuberculous meningitis admitted to intensive care unit. Retrospective cohort study including all adult patients admitted to intensive care unit for tuberculous meningitis between January 1993 and December 2005. A propensity score case matching was performed using a multivariable logistic regression model, and matched pairs were examined for baseline characteristics and outcome by using conditional regression model. A multivariate Cox's proportional hazard model was used to assess the effects of corticosteroids in all patients adjusting for propensity score. The primary outcome was mortality at 60 days and the secondary outcome was the density of incidence of nosocomial infections. Two hundred and seventy patients were included. The mean age was 38+/-17 years, and the Glasgow coma scale was 12+/-3. The overall mortality was 43.3%. Ninety-four patients who had received corticosteroids were matched to 94 patients untreated with corticosteroids by the propensity score. The baseline characteristics were similar in the two groups except for hydrocephalus, which was more frequent in the group corticosteroids. The mortality rate was 47.9% in group Corticosteroids and 52.1% in group No corticosteroids (P=0.77). The case fatality rate in stage III patients, according to the British Medical Research Council criteria, was 61.5% in the group Corticosteroids versus 74.1% in the group No corticosteroids (P=0.33). Nosocomial infections were observed in 19.1 by 1000 days patient in group Corticosteroids versus 16.1 by 1000 days patient in group No corticosteroids (P=0.4). The outcome in all patients after adjusting for propensity score showed the same results. This study found no significant improvement in survival in adult patients with tuberculous meningitis admitted to intensive care who received dexamethasone. However, the confidence interval was in accordance with the 0.78 relative risk estimated by the meta-analysis Cochrane version 2008. There was no significant difference for nosocomial infections between the group Corticosteroids and the group No corticosteroids. A probable
doi_str_mv 10.1016/j.revmed.2008.06.023
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_66770123</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66770123</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-3ad1f48a471d904474c9b22293c214311d5bf5ac97bd5e0491ad3e016c524ba83</originalsourceid><addsrcrecordid>eNo1kMlOwzAQhn0A0VJ4A4R84pbgLYu5oaosUiUucI4cewKuEifYTlEPvDtGlNNI_3ya5UPoipKcElre7nIP-wFMzgipc1LmhPETtCRM1FldlnyBzkPYEUISLc_QgtYVKSsul-h703WgY8Bjh_Xoo9VjiOBHa1LksDJzn5pfNn7gOLfg9dyPc8ADOOvebbQhIYONEQyOI7Yuggt2D1grD3h2Nt5hhSc_Tr95POCQlgBWTvWHYMMFOu1UH-DyWFfo7WHzun7Kti-Pz-v7bTZRLmPGlaGdqJWoqJFEiEpo2TLGJNeMCk6pKdquUFpWrSmACEmV4ZDE6IKJVtV8hW7-5qZLPmcIsRls0ND3ykF6pynLqiKU8QReH8G5TT6bydtB-UPzL4z_AGL4cD0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66770123</pqid></control><display><type>article</type><title>Effects of corticosteroids on adults with tuberculous meningitis admitted to intensive care unit: a propensity score analysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Madani, N ; Dendane, T ; Zekraoui, A ; Abidi, K ; Zeggwagh, A A ; Abouqal, R</creator><creatorcontrib>Madani, N ; Dendane, T ; Zekraoui, A ; Abidi, K ; Zeggwagh, A A ; Abouqal, R</creatorcontrib><description>The beneficial effect of corticosteroids has been well established, particularly in patients free of infection with the human immunodeficiency virus. In intensive care units, the high risks of infection to which patients are exposed specifically could offset the neurological benefit of corticosteroids. The purpose of the study was to assess the effects of corticosteroids in adult patients with tuberculous meningitis admitted to intensive care unit. Retrospective cohort study including all adult patients admitted to intensive care unit for tuberculous meningitis between January 1993 and December 2005. A propensity score case matching was performed using a multivariable logistic regression model, and matched pairs were examined for baseline characteristics and outcome by using conditional regression model. A multivariate Cox's proportional hazard model was used to assess the effects of corticosteroids in all patients adjusting for propensity score. The primary outcome was mortality at 60 days and the secondary outcome was the density of incidence of nosocomial infections. Two hundred and seventy patients were included. The mean age was 38+/-17 years, and the Glasgow coma scale was 12+/-3. The overall mortality was 43.3%. Ninety-four patients who had received corticosteroids were matched to 94 patients untreated with corticosteroids by the propensity score. The baseline characteristics were similar in the two groups except for hydrocephalus, which was more frequent in the group corticosteroids. The mortality rate was 47.9% in group Corticosteroids and 52.1% in group No corticosteroids (P=0.77). The case fatality rate in stage III patients, according to the British Medical Research Council criteria, was 61.5% in the group Corticosteroids versus 74.1% in the group No corticosteroids (P=0.33). Nosocomial infections were observed in 19.1 by 1000 days patient in group Corticosteroids versus 16.1 by 1000 days patient in group No corticosteroids (P=0.4). The outcome in all patients after adjusting for propensity score showed the same results. This study found no significant improvement in survival in adult patients with tuberculous meningitis admitted to intensive care who received dexamethasone. However, the confidence interval was in accordance with the 0.78 relative risk estimated by the meta-analysis Cochrane version 2008. There was no significant difference for nosocomial infections between the group Corticosteroids and the group No corticosteroids. A probable lack of statistical power may explain these results.</description><identifier>ISSN: 0248-8663</identifier><identifier>DOI: 10.1016/j.revmed.2008.06.023</identifier><identifier>PMID: 18706739</identifier><language>fre</language><publisher>France</publisher><subject>Adolescent ; Adult ; Aged ; Anti-Bacterial Agents - administration &amp; dosage ; Anti-Bacterial Agents - therapeutic use ; Anti-Inflammatory Agents - administration &amp; dosage ; Anti-Inflammatory Agents - therapeutic use ; Brain - diagnostic imaging ; Cohort Studies ; Cross Infection - epidemiology ; Data Interpretation, Statistical ; Dexamethasone - administration &amp; dosage ; Dexamethasone - therapeutic use ; Glucocorticoids - administration &amp; dosage ; Glucocorticoids - therapeutic use ; Humans ; Intensive Care Units ; Middle Aged ; Multivariate Analysis ; Randomized Controlled Trials as Topic ; Retrospective Studies ; Survival Analysis ; Tomography, X-Ray Computed ; Tuberculosis, Meningeal - diagnosis ; Tuberculosis, Meningeal - diagnostic imaging ; Tuberculosis, Meningeal - drug therapy ; Tuberculosis, Meningeal - mortality</subject><ispartof>La revue de medecine interne, 2009-01, Vol.30 (1), p.12-19</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18706739$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Madani, N</creatorcontrib><creatorcontrib>Dendane, T</creatorcontrib><creatorcontrib>Zekraoui, A</creatorcontrib><creatorcontrib>Abidi, K</creatorcontrib><creatorcontrib>Zeggwagh, A A</creatorcontrib><creatorcontrib>Abouqal, R</creatorcontrib><title>Effects of corticosteroids on adults with tuberculous meningitis admitted to intensive care unit: a propensity score analysis</title><title>La revue de medecine interne</title><addtitle>Rev Med Interne</addtitle><description>The beneficial effect of corticosteroids has been well established, particularly in patients free of infection with the human immunodeficiency virus. In intensive care units, the high risks of infection to which patients are exposed specifically could offset the neurological benefit of corticosteroids. The purpose of the study was to assess the effects of corticosteroids in adult patients with tuberculous meningitis admitted to intensive care unit. Retrospective cohort study including all adult patients admitted to intensive care unit for tuberculous meningitis between January 1993 and December 2005. A propensity score case matching was performed using a multivariable logistic regression model, and matched pairs were examined for baseline characteristics and outcome by using conditional regression model. A multivariate Cox's proportional hazard model was used to assess the effects of corticosteroids in all patients adjusting for propensity score. The primary outcome was mortality at 60 days and the secondary outcome was the density of incidence of nosocomial infections. Two hundred and seventy patients were included. The mean age was 38+/-17 years, and the Glasgow coma scale was 12+/-3. The overall mortality was 43.3%. Ninety-four patients who had received corticosteroids were matched to 94 patients untreated with corticosteroids by the propensity score. The baseline characteristics were similar in the two groups except for hydrocephalus, which was more frequent in the group corticosteroids. The mortality rate was 47.9% in group Corticosteroids and 52.1% in group No corticosteroids (P=0.77). The case fatality rate in stage III patients, according to the British Medical Research Council criteria, was 61.5% in the group Corticosteroids versus 74.1% in the group No corticosteroids (P=0.33). Nosocomial infections were observed in 19.1 by 1000 days patient in group Corticosteroids versus 16.1 by 1000 days patient in group No corticosteroids (P=0.4). The outcome in all patients after adjusting for propensity score showed the same results. This study found no significant improvement in survival in adult patients with tuberculous meningitis admitted to intensive care who received dexamethasone. However, the confidence interval was in accordance with the 0.78 relative risk estimated by the meta-analysis Cochrane version 2008. There was no significant difference for nosocomial infections between the group Corticosteroids and the group No corticosteroids. A probable lack of statistical power may explain these results.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Anti-Inflammatory Agents - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Brain - diagnostic imaging</subject><subject>Cohort Studies</subject><subject>Cross Infection - epidemiology</subject><subject>Data Interpretation, Statistical</subject><subject>Dexamethasone - administration &amp; dosage</subject><subject>Dexamethasone - therapeutic use</subject><subject>Glucocorticoids - administration &amp; dosage</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Intensive Care Units</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Retrospective Studies</subject><subject>Survival Analysis</subject><subject>Tomography, X-Ray Computed</subject><subject>Tuberculosis, Meningeal - diagnosis</subject><subject>Tuberculosis, Meningeal - diagnostic imaging</subject><subject>Tuberculosis, Meningeal - drug therapy</subject><subject>Tuberculosis, Meningeal - mortality</subject><issn>0248-8663</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kMlOwzAQhn0A0VJ4A4R84pbgLYu5oaosUiUucI4cewKuEifYTlEPvDtGlNNI_3ya5UPoipKcElre7nIP-wFMzgipc1LmhPETtCRM1FldlnyBzkPYEUISLc_QgtYVKSsul-h703WgY8Bjh_Xoo9VjiOBHa1LksDJzn5pfNn7gOLfg9dyPc8ADOOvebbQhIYONEQyOI7Yuggt2D1grD3h2Nt5hhSc_Tr95POCQlgBWTvWHYMMFOu1UH-DyWFfo7WHzun7Kti-Pz-v7bTZRLmPGlaGdqJWoqJFEiEpo2TLGJNeMCk6pKdquUFpWrSmACEmV4ZDE6IKJVtV8hW7-5qZLPmcIsRls0ND3ykF6pynLqiKU8QReH8G5TT6bydtB-UPzL4z_AGL4cD0</recordid><startdate>200901</startdate><enddate>200901</enddate><creator>Madani, N</creator><creator>Dendane, T</creator><creator>Zekraoui, A</creator><creator>Abidi, K</creator><creator>Zeggwagh, A A</creator><creator>Abouqal, R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200901</creationdate><title>Effects of corticosteroids on adults with tuberculous meningitis admitted to intensive care unit: a propensity score analysis</title><author>Madani, N ; Dendane, T ; Zekraoui, A ; Abidi, K ; Zeggwagh, A A ; Abouqal, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-3ad1f48a471d904474c9b22293c214311d5bf5ac97bd5e0491ad3e016c524ba83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2009</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Anti-Inflammatory Agents - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Brain - diagnostic imaging</topic><topic>Cohort Studies</topic><topic>Cross Infection - epidemiology</topic><topic>Data Interpretation, Statistical</topic><topic>Dexamethasone - administration &amp; dosage</topic><topic>Dexamethasone - therapeutic use</topic><topic>Glucocorticoids - administration &amp; dosage</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Intensive Care Units</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Retrospective Studies</topic><topic>Survival Analysis</topic><topic>Tomography, X-Ray Computed</topic><topic>Tuberculosis, Meningeal - diagnosis</topic><topic>Tuberculosis, Meningeal - diagnostic imaging</topic><topic>Tuberculosis, Meningeal - drug therapy</topic><topic>Tuberculosis, Meningeal - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Madani, N</creatorcontrib><creatorcontrib>Dendane, T</creatorcontrib><creatorcontrib>Zekraoui, A</creatorcontrib><creatorcontrib>Abidi, K</creatorcontrib><creatorcontrib>Zeggwagh, A A</creatorcontrib><creatorcontrib>Abouqal, R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>La revue de medecine interne</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Madani, N</au><au>Dendane, T</au><au>Zekraoui, A</au><au>Abidi, K</au><au>Zeggwagh, A A</au><au>Abouqal, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of corticosteroids on adults with tuberculous meningitis admitted to intensive care unit: a propensity score analysis</atitle><jtitle>La revue de medecine interne</jtitle><addtitle>Rev Med Interne</addtitle><date>2009-01</date><risdate>2009</risdate><volume>30</volume><issue>1</issue><spage>12</spage><epage>19</epage><pages>12-19</pages><issn>0248-8663</issn><abstract>The beneficial effect of corticosteroids has been well established, particularly in patients free of infection with the human immunodeficiency virus. In intensive care units, the high risks of infection to which patients are exposed specifically could offset the neurological benefit of corticosteroids. The purpose of the study was to assess the effects of corticosteroids in adult patients with tuberculous meningitis admitted to intensive care unit. Retrospective cohort study including all adult patients admitted to intensive care unit for tuberculous meningitis between January 1993 and December 2005. A propensity score case matching was performed using a multivariable logistic regression model, and matched pairs were examined for baseline characteristics and outcome by using conditional regression model. A multivariate Cox's proportional hazard model was used to assess the effects of corticosteroids in all patients adjusting for propensity score. The primary outcome was mortality at 60 days and the secondary outcome was the density of incidence of nosocomial infections. Two hundred and seventy patients were included. The mean age was 38+/-17 years, and the Glasgow coma scale was 12+/-3. The overall mortality was 43.3%. Ninety-four patients who had received corticosteroids were matched to 94 patients untreated with corticosteroids by the propensity score. The baseline characteristics were similar in the two groups except for hydrocephalus, which was more frequent in the group corticosteroids. The mortality rate was 47.9% in group Corticosteroids and 52.1% in group No corticosteroids (P=0.77). The case fatality rate in stage III patients, according to the British Medical Research Council criteria, was 61.5% in the group Corticosteroids versus 74.1% in the group No corticosteroids (P=0.33). Nosocomial infections were observed in 19.1 by 1000 days patient in group Corticosteroids versus 16.1 by 1000 days patient in group No corticosteroids (P=0.4). The outcome in all patients after adjusting for propensity score showed the same results. This study found no significant improvement in survival in adult patients with tuberculous meningitis admitted to intensive care who received dexamethasone. However, the confidence interval was in accordance with the 0.78 relative risk estimated by the meta-analysis Cochrane version 2008. There was no significant difference for nosocomial infections between the group Corticosteroids and the group No corticosteroids. A probable lack of statistical power may explain these results.</abstract><cop>France</cop><pmid>18706739</pmid><doi>10.1016/j.revmed.2008.06.023</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0248-8663
ispartof La revue de medecine interne, 2009-01, Vol.30 (1), p.12-19
issn 0248-8663
language fre
recordid cdi_proquest_miscellaneous_66770123
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adolescent
Adult
Aged
Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - therapeutic use
Anti-Inflammatory Agents - administration & dosage
Anti-Inflammatory Agents - therapeutic use
Brain - diagnostic imaging
Cohort Studies
Cross Infection - epidemiology
Data Interpretation, Statistical
Dexamethasone - administration & dosage
Dexamethasone - therapeutic use
Glucocorticoids - administration & dosage
Glucocorticoids - therapeutic use
Humans
Intensive Care Units
Middle Aged
Multivariate Analysis
Randomized Controlled Trials as Topic
Retrospective Studies
Survival Analysis
Tomography, X-Ray Computed
Tuberculosis, Meningeal - diagnosis
Tuberculosis, Meningeal - diagnostic imaging
Tuberculosis, Meningeal - drug therapy
Tuberculosis, Meningeal - mortality
title Effects of corticosteroids on adults with tuberculous meningitis admitted to intensive care unit: a propensity score analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T07%3A01%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20corticosteroids%20on%20adults%20with%20tuberculous%20meningitis%20admitted%20to%20intensive%20care%20unit:%20a%20propensity%20score%20analysis&rft.jtitle=La%20revue%20de%20medecine%20interne&rft.au=Madani,%20N&rft.date=2009-01&rft.volume=30&rft.issue=1&rft.spage=12&rft.epage=19&rft.pages=12-19&rft.issn=0248-8663&rft_id=info:doi/10.1016/j.revmed.2008.06.023&rft_dat=%3Cproquest_pubme%3E66770123%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66770123&rft_id=info:pmid/18706739&rfr_iscdi=true